Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Allergy & Clinical Immunology

Reuters Health • The Doctor's Channel Daily Newscast

New drug may offer better protection against respiratory syncytial virus

NEW YORK (Reuters Health) – An investigational drug called motavizumab may offer better protection against respiratory syncytial virus (RSV) than palivizumab in high risk children, according to a report in the January issue of Pediatrics. Although...

Reuters Health • The Doctor's Channel Daily Newscast

Adverse events common with low- to medium-dose glucocorticoids

NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by researchers in the Netherlands. In fact, they report in the...

Reuters Health • The Doctor's Channel Daily Newscast

Cancer risk not affected by anti-TNF therapies for rheumatoid arthritis

NEW YORK (Reuters Health) – Anti-tumor necrosis factor (TNF) agents do not increase the risk of cancer during the first few years of use for rheumatoid arthritis, according to one of the largest and longest duration population-based assessments to...

Back Pain